{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:23:21Z","timestamp":1783059801192,"version":"3.54.6"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["QKHJC-ZK [2022]YB297"],"award-info":[{"award-number":["QKHJC-ZK [2022]YB297"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["TCZJZ [2022]03"],"award-info":[{"award-number":["TCZJZ [2022]03"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560847"],"award-info":[{"award-number":["82560847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22261011"],"award-info":[{"award-number":["22261011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010828","name":"Department of Education of Guizhou Province","doi-asserted-by":"publisher","award":["QJJ [2024]97"],"award-info":[{"award-number":["QJJ [2024]97"]}],"id":[{"id":"10.13039\/501100010828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["CXPTXM [2025]010\/[2025]021\/KXJZ [2025]014"],"award-info":[{"award-number":["CXPTXM [2025]010\/[2025]021\/KXJZ [2025]014"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YB240"],"award-info":[{"award-number":["YB240"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YB641"],"award-info":[{"award-number":["YB641"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015960","name":"State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018606","name":"The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cbi.2026.112141","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:12:28Z","timestamp":1778825548000},"page":"112141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The novel \u03b4,\u03b3-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming"],"prefix":"10.1016","volume":"435","author":[{"given":"Lihao","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0696-2668","authenticated-orcid":false,"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cbi.2026.112141_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cbi.2026.112141_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ajh.27625","article-title":"Acute myeloid leukemia: 2025 update on diagnosis, Risk-stratification, and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.cbi.2026.112141_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-021-01060-8","article-title":"Erythroleukemia: an update","volume":"23","author":"Weinberg","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.cbi.2026.112141_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116256","article-title":"Acute erythroid leukemia: from molecular biology to clinical outcomes","volume":"25","author":"Fernandes","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cbi.2026.112141_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1566524021666210121142316","article-title":"Chemotherapeutics for Acute Erythroid leukemia: research, present and future","volume":"21","author":"Liao","year":"2021","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112141_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2026.112141_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-020-00222-9","article-title":"Fructose contributes to the Warburg effect for cancer growth","volume":"8","author":"Nakagawa","year":"2020","journal-title":"Cancer Metabol."},{"issue":"12","key":"10.1016\/j.cbi.2026.112141_bib8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41418-024-01393-4","article-title":"AKR1B1-dependent fructose metabolism enhances malignancy of cancer cells","volume":"31","author":"Zhao","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2026.112141_bib9","article-title":"Fructose-induced metabolic reprogramming of cancer cells","volume":"15","author":"Ting","year":"2024","journal-title":"Front. Immunol."},{"issue":"8043","key":"10.1016\/j.cbi.2026.112141_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-024-08258-3","article-title":"Dietary fructose enhances tumour growth indirectly via interorgan lipid transfer","volume":"636","author":"Fowle-Grider","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cbi.2026.112141_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41418-024-01415-1","article-title":"Polyol pathway-generated fructose is indispensable for growth and survival of non-small cell lung cancer","volume":"32","author":"Schwab","year":"2025","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1016\/j.cbi.2026.112141_bib12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1158\/0008-5472.CAN-17-2834","article-title":"Polyol pathway links glucose metabolism to the aggressiveness of cancer cells","volume":"78","author":"Schwab","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2026.112141_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/5584_2021_634","article-title":"Aldo Keto Reductases AKR1B1 and AKR1B10 in cancer: molecular mechanisms and signaling networks","volume":"1347","author":"Banerjee","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112141_bib14","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.bmcl.2009.02.037","article-title":"Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications","volume":"19","author":"Van Zandt","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.cbi.2026.112141_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0031-6997(24)01347-4","article-title":"Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications","volume":"50","author":"Yabe-Nishimura","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.cbi.2026.112141_bib16","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41418-024-01393-4","article-title":"AKR1B1-dependent fructose metabolism enhances malignancy of cancer cells","volume":"31","author":"Zhao","year":"2024","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.cbi.2026.112141_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122635","article-title":"Fructose metabolism in cancer","volume":"9","author":"Krause","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cbi.2026.112141_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2174\/1389201025666230830125147","article-title":"The role of aldose reductase in Polyol pathway: an emerging pharmacological target in diabetic complications and associated morbidities","volume":"25","author":"Gupta","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.cbi.2026.112141_bib19","article-title":"AKR1B1 is required for maintaining acute leukemia cell survival by epigenetic silencing of tumor suppressor genes","author":"Chen","year":"2024","journal-title":"Biochem. Genet."},{"issue":"614","key":"10.1016\/j.cbi.2026.112141_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg6428","article-title":"Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112141_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41392-025-02321-9","article-title":"Targeting AKR1B1 inhibits metabolic reprogramming to reverse systemic therapy resistance in hepatocellular carcinoma","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2026.112141_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216277","article-title":"LINC00978 regulates metabolic rewiring to promote the malignancy of glioblastoma through AKR1B1","volume":"567","author":"Meng","year":"2023","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cbi.2026.112141_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ccell.2016.09.006","article-title":"Enhanced fructose utilization mediated by SLC2A5 is a unique metabolic feature of Acute Myeloid leukemia with therapeutic potential","volume":"30","author":"Chen","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cbi.2026.112141_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fphar.2012.00104","article-title":"Expression of the aldo-ketoreductases AKR1B1 and AKR1B10 in human cancers","volume":"3","author":"Laffin","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.cbi.2026.112141_bib25","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.devcel.2024.04.023","article-title":"SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis","volume":"59","author":"Yu","year":"2024","journal-title":"Dev. Cell"},{"issue":"3","key":"10.1016\/j.cbi.2026.112141_bib26","first-page":"458","article-title":"Behavioral, biochemical, and in Silico evidence for extraction-dependent neuroprotective effects of citrus limon leaf essential oils in scopolamine-challenged","volume":"19","author":"Bouabdallah","year":"2026","journal-title":"Zebrafish"},{"key":"10.1016\/j.cbi.2026.112141_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-3-032-08530-6_8","article-title":"An overview of targeting some cancer hallmarks with plant polyphenols: a step toward precision","volume":"114","author":"Hamdy","year":"2026","journal-title":"Sub-cellular biochemistry"},{"issue":"9","key":"10.1016\/j.cbi.2026.112141_bib28","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytother Res. : PT"},{"key":"10.1016\/j.cbi.2026.112141_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108752","article-title":"New drug discovery and development from natural products: advances and strategies","volume":"264","author":"Wang","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.cbi.2026.112141_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11061125","article-title":"Molecular mechanisms behind safranal's toxicity to HepG2 cells from dual omics","volume":"11","author":"Nelson","year":"2022","journal-title":"Antioxidants"},{"issue":"16","key":"10.1016\/j.cbi.2026.112141_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164063","article-title":"Combining Crocin and Sorafenib improves their tumor-inhibiting effects in a rat model of diethylnitrosamine-induced cirrhotic-hepatocellular carcinoma","volume":"15","author":"Awad","year":"2023","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.cbi.2026.112141_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2026.112141_bib33","article-title":"Targeting cancer signaling pathways by natural products: exploring promising anti-cancer agents","volume":"150","author":"Hashem","year":"2022","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"9","key":"10.1016\/j.cbi.2026.112141_bib34","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1039\/D4OB02014F","article-title":"Unexpected amine-triggered skeletal modification of fascaplysin and its derivatives: rapid access to \u03b4,\u03b3-biscarbolines","volume":"23","author":"Wang","year":"2025","journal-title":"Org. Biomol. Chem."},{"issue":"15","key":"10.1016\/j.cbi.2026.112141_bib35","first-page":"8375","article-title":"Natural alkaloids in cancer therapy: berberine","volume":"25","author":"Duda-Madej","year":"2024","journal-title":"Sanguinarine and Chelerythrine against Colorectal and Gastric Cancer"},{"key":"10.1016\/j.cbi.2026.112141_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2024.106222","article-title":"Alkaloids in cancer therapy: targeting the tumor microenvironment and metastasis signaling pathways","volume":"179","author":"Koochaki","year":"2024","journal-title":"Fitoterapia"},{"issue":"5","key":"10.1016\/j.cbi.2026.112141_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(91)90428-2","article-title":"Friend virus-induced erythroleukemia and the multistage nature of cancer","volume":"66","author":"Ben-David","year":"1991","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cbi.2026.112141_bib38","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","article-title":"Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus","volume":"87","author":"Ben-David","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cbi.2026.112141_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00018-022-04160-1","article-title":"Current insights into the role of Fli-1 in hematopoiesis and malignant transformation","volume":"79","author":"Ben-David","year":"2022","journal-title":"Cell. Mol. Life Sci. : CM"},{"issue":"2","key":"10.1016\/j.cbi.2026.112141_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12032-022-01867-w","article-title":"FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L\/R and other glycolytic genes","volume":"40","author":"Sheng","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.cbi.2026.112141_bib41","article-title":"A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K\/AKT\/FOXO3a axis and TNF signaling pathway","volume":"177","author":"Dinghuan","year":"2024","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"24","key":"10.1016\/j.cbi.2026.112141_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413426","article-title":"The Astragalus Membranaceus herb Attenuates leukemia by inhibiting the FLI1 oncogene and enhancing anti-tumor immunity","volume":"25","author":"Yu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.cbi.2026.112141_bib43","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"W1","key":"10.1016\/j.cbi.2026.112141_bib44","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.cbi.2026.112141_bib45","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"issue":"W1","key":"10.1016\/j.cbi.2026.112141_bib46","doi-asserted-by":"crossref","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.cbi.2026.112141_bib47","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s10637-025-01581-0","article-title":"Comparative analysis of the effects of PSPH and PHGDH inhibitors on tumor cell proliferation","volume":"43","author":"Wang","year":"2025","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.cbi.2026.112141_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1564199","article-title":"L1, a 3,3'-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1\/AKT pathway in erythroleukemia HEL cells","volume":"16","author":"Kuang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2026.112141_bib49","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/10428194.2018.1494270","article-title":"Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia","volume":"60","author":"Kuttikrishnan","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.cbi.2026.112141_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098113","article-title":"Cytostatic activity of sanguinarine and a cyanide derivative in human erythroleukemia cells is mediated by suppression of c-MET\/MAPK signaling","volume":"24","author":"Xu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cbi.2026.112141_bib51","first-page":"136","article-title":"Berberine targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia with IDH1 mutation","volume":"21","author":"Huang","year":"2023","journal-title":"Chin. J. Nat. Med."},{"issue":"3a","key":"10.1016\/j.cbi.2026.112141_bib52","first-page":"2159","article-title":"Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia","volume":"23","author":"Lee","year":"2003","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.cbi.2026.112141_bib53","first-page":"347","article-title":"Alterations in hemorheological properties of erythrocytes in nude mice with erythroleukemia and the treatment effects of etoposide","volume":"33","author":"Xu","year":"2005","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"6","key":"10.1016\/j.cbi.2026.112141_bib54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1566524016666160523143937","article-title":"The role of the PERK\/eIF2\u03b1\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress","volume":"16","author":"Rozpedek","year":"2016","journal-title":"Curr. Mol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112141_bib55","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41419-025-07949-7","article-title":"Cathepsin D promotes acute myeloid leukemia progression through stabilization of the anti-apoptotic proteins","volume":"16","author":"Jiang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2026.112141_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175191","article-title":"Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer","volume":"931","author":"Bailly","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112141_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103640","article-title":"In vitro studies of potent aldose reductase inhibitors: synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives","volume":"97","author":"Celestina","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2026.112141_bib58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41419-019-1363-1","article-title":"Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.cbi.2026.112141_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179322","article-title":"Common genetic aberrations associated with metabolic interferences in human Type-2 diabetes and Acute Myeloid leukemia: a bioinformatics approach","volume":"22","author":"Kyriakou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112141_bib60","article-title":"Childhood acute leukemia and type 1 diabetes in children: a nationwide case-control study","author":"Ventel\u00e4","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cbi.2026.112141_bib61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s40001-024-02022-z","article-title":"Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia","volume":"29","author":"Liu","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.cbi.2026.112141_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/13543776.2019.1582646","article-title":"Aldose reductase inhibitors: 2013-present","volume":"29","author":"Quattrini","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"10.1016\/j.cbi.2026.112141_bib63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/157489209789206931","article-title":"Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives","volume":"4","author":"Liu","year":"2009","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"4","key":"10.1016\/j.cbi.2026.112141_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040485","article-title":"In search of differential inhibitors of aldose reductase","volume":"12","author":"Balestri","year":"2022","journal-title":"Biomolecules"},{"issue":"16","key":"10.1016\/j.cbi.2026.112141_bib65","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1111\/jcmm.15581","article-title":"Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential","volume":"24","author":"Khayami","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.cbi.2026.112141_bib66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hlife.2023.12.002","article-title":"Aldo-keto reductase 1B: much learned, much more to do","volume":"2","author":"Zhao","year":"2024","journal-title":"hLife"},{"issue":"16","key":"10.1016\/j.cbi.2026.112141_bib67","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/onc.2014.162","article-title":"The ets transcription factor Fli-1 in development, cancer and disease","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2026.112141_bib68","author":"Arribas"},{"key":"10.1016\/j.cbi.2026.112141_bib69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fphar.2012.00148","article-title":"Aldo-Keto reductases 1B in endocrinology and metabolism","volume":"3","author":"Pastel","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cbi.2026.112141_bib70","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1039\/D3CP05985E","article-title":"Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition","volume":"26","author":"Liu","year":"2024","journal-title":"Phys. Chem. Chem. Phys. : Phys. Chem. Chem. Phys."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726002498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726002498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:51:29Z","timestamp":1783057889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726002498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":70,"alternative-id":["S0009279726002498"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112141","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel \u03b4,\u03b3-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112141"}}